Eucreas 50mg / 850mg and 50mg / 1000mg film-coated tablets
- Name:
Eucreas 50mg / 850mg and 50mg / 1000mg film-coated tablets
- Company:
Novartis Ireland Limited
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may be renewed (B)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 02/09/20

Click on this link to Download PDF directly
Novartis Ireland Limited

Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 2 September 2020 PIL
Reasons for updating
- Change to section 4 - how to report a side effect
- Change to section 6 - manufacturer
Updated on 15 June 2020 SPC
Reasons for updating
- Change to section 6.3 - Shelf life
- Change to section 6.5 - Nature and contents of container
- Change to section 8 - Marketing authorisation number(s)
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Approval of new triplex blister packs
Updated on 28 November 2019 PIL
Reasons for updating
- Improved presentation of PIL
Updated on 28 November 2019 PIL
Reasons for updating
- Improved presentation of PIL
Updated on 28 November 2019 PIL
Reasons for updating
- Improved presentation of PIL
Updated on 2 April 2019 SPC
Reasons for updating
- File format updated to PDF
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 23 October 2018 PIL
Reasons for updating
- Change to section 6 - marketing authorisation holder
Updated on 17 May 2018 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 15 May 2018 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 14 May 2018 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 9 August 2017 PIL
Reasons for updating
- New PIL for new product
Updated on 9 August 2017 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - pregnancy, breast feeding and fertility
Updated on 6 June 2017 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 11 April 2017 PIL
Reasons for updating
- Improved presentation of PIL
Updated on 11 April 2017 PIL
Reasons for updating
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 3 - how to take/use
- Change to section 4 - possible side effects
Updated on 30 August 2016 PIL
Reasons for updating
- Addition of information on reporting a side effect.
Updated on 1 September 2015 PIL
Reasons for updating
- Change to side-effects
- Change to MA holder contact details
Updated on 19 June 2014 PIL
Reasons for updating
- Change to side-effects
Updated on 11 October 2013 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change to side-effects
- Change to dosage and administration
Updated on 5 December 2012 PIL
Reasons for updating
- Change to, or new use for medicine
- Change to side-effects
Updated on 8 November 2012 PIL
Reasons for updating
- Change to side-effects
- Change to improve clarity and readability
Updated on 3 January 2012 PIL
Reasons for updating
- Change to warnings or special precautions for use
Updated on 18 August 2011 PIL
Reasons for updating
- Change to further information section
Updated on 22 September 2010 PIL
Reasons for updating
- Change to side-effects
Updated on 9 June 2010 PIL
Reasons for updating
- Change to MA holder contact details
Updated on 8 October 2009 PIL
Reasons for updating
- Change to side-effects
Updated on 5 May 2009 PIL
Reasons for updating
- New PIL for new product